echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Nature Medicine: Patients with colorectal cancer get the new crown vaccine...

    Nature Medicine: Patients with colorectal cancer get the new crown vaccine...

    • Last Update: 2021-06-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Currently, the global COVID-19 vaccination plan prioritizes cancer patients, including the use of mRNA vaccines


    CRS/cytokine storm is a systemic inflammatory response characterized by excessive release of cytokines (ie, INF-γ, IL-6, IL-10, and IL-2R are elevated)


    A 58-year-old man started anti-PD -1 monotherapy (an experimental ICI in an ongoing interventional clinical trial; NCT02715284) for colorectal cancer (MMRd CRC) with mismatch repair defects that have metastasized to the mesentery and rectus ) Treatment


    Given that cancer patients are excluded from the SARS-CoV-2 vaccine research and are currently in a priority position in the global COVID-19 vaccination program, this case prompts people to look forward to the safety of the COVID-19 vaccine in cancer patients Pharmacovigilance


    references

    references

    Lewis Au et al.


    Lewis Au et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.